NSE filing, NSE: VIJIFIN. Summary written from the filing by ALFA Finder's alert engine.
Viji Finance Ltd: key numbers
- Share price
- ₹15.08
- Market cap
- ₹348.4 Cr
- Revenue (annual)
- ₹5.08 Cr
- Net profit (annual)
- ₹1.97 Cr
- P/E (TTM)
- 60.7×Sector 19.7×
- Promoter holding
- 30.07%-9.24% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Viji Finance Ltd
All →Viji Finance Annual General Meeting
Viji Finance submitted a postal ballot notice to approve appointment of DDS & Associates as statutory auditors. The vote addresses the vacancy from the prior firm's resignation.
Viji Finance Other Announcement
Viji Finance Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026. This periodic disclosure reflects the company's capital structure as of that date.
Viji Finance Q2 FY27 Results: Turns Profitable, Net Profit ₹1.5 Cr
Viji Finance Ltd reported revenue from operations of ₹2.8 Cr (+366.7% YoY) and net profit of ₹1.5 Cr for Q2 FY27.
- Key figure
- Net profit ₹1.5 Cr
Viji Finance Capital Structure Change
Viji Finance Ltd received listing approval from BSE and NSE for 1 crore equity shares issued upon conversion of warrants, valued at ₹2.80 Crore.
- Value
- ₹2.80 Cr
Viji Finance Board Meeting Date
Viji Finance has scheduled its Board meeting for 14 October 2026 to consider Q2/H1 results. No decisions have been taken yet; agenda items are proposed only.
Viji Finance Capital Structure Change
Viji Finance Limited received trading approval from BSE and NSE for 2,95,00,000 equity shares issued to non-promoters upon the conversion of warrants.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.